{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:45:45Z","timestamp":1791459945771,"version":"4.3.4"},"reference-count":50,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Realizing Effectiveness Across Continents with Hydroxyurea (REACH, NCT01966731) provides hydroxyurea at maximum tolerated dose (MTD) for children with sickle cell anemia (SCA) in sub-Saharan Africa. Beyond reducing SCA-related clinical events, documented treatment benefits include \u223c50% reduction in malaria incidence. To identify associations and propose mechanisms by which hydroxyurea could be associated with lower malaria rates, infections were recorded across all clinical sites (Angola, Democratic Republic of Congo, Kenya, and Uganda). Hazard ratios (HR) with 95% confidence intervals (CIs) for baseline demographics, and time-varying laboratory and clinical parameters were estimated in a modified Cox gap-time model for repeated events. Over 3387 patient-years of hydroxyurea treatment, 717 clinical malaria episodes occurred in 336 of 606 study participants; over half were confirmed by blood smear and\/or rapid diagnostic testing with 97.8% Plasmodium falciparum. In univariate analysis limited to 4 confirmed infections per child, malaria risk was significantly associated with absolute neutrophil count (ANC), splenomegaly, hemoglobin, and achieving MTD; age, malaria season, MTD dose, fetal hemoglobin, \u03b1-thalassemia, and glucose-6-phosphate dehydrogenase deficiency had no effect. In multivariable regression of confirmed infections, ANC was significant (HR, 1.37 per doubled value; 95% CI, 1.10-1.70; P\u00a0=\u00a0.0052), and ANC values &amp;lt;3.0\u00a0\u00d7 109\/L were associated with lower malaria incidence. Compared with nonpalpable spleen, 1- to 4-cm splenomegaly also was associated with higher malaria risk (HR, 2.01; 95% CI, 1.41-2.85; P\u00a0= .0001). Hydroxyurea at MTD is associated with lower malaria incidence in SCA through incompletely defined mechanisms, but treatment-associated mild myelosuppression with ANC &amp;lt;3.0\u00a0\u00d7 109\/L is salutary. Splenomegaly is an unexplained risk factor for malaria infections among children with SCA in Africa.<\/jats:p>","DOI":"10.1182\/blood.2022017051","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T21:05:21Z","timestamp":1668459921000},"page":"1402-1410","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":27,"title":["Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa"],"prefix":"10.1182","volume":"141","author":[{"given":"Peter","family":"Olupot-Olupot","sequence":"first","affiliation":[{"name":"1Mbale Clinical Research Institute, Mbale, Uganda"},{"name":"2Mbale Regional Referral and Teaching Hospital\/Busitema University, Mbale, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9328-6399","authenticated-orcid":false,"given":"George","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"3Department of Medicine, University Health Network and Mt Sinai Hospital, Toronto, ON, Canada"},{"name":"4University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4456-2382","authenticated-orcid":false,"given":"Thomas N.","family":"Williams","sequence":"additional","affiliation":[{"name":"5KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya"},{"name":"6Institute of Global Health Innovation, Imperial College, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9on","family":"Tshilolo","sequence":"additional","affiliation":[{"name":"7Institut de Recherche Biom\u00e9dicale in CEFA\/Centre Hospitalier Monkole, Kinshasa, Democratic Republic of Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Br\u00edgida","family":"Santos","sequence":"additional","affiliation":[{"name":"8Hospital Pedi\u00e1trico David Bernardino, Luanda, Angola"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4083-0060","authenticated-orcid":false,"given":"Luke R.","family":"Smart","sequence":"additional","affiliation":[{"name":"9Division of Hematology, Department of Pediatrics, Cincinnati Children\u2019s Hospital, Cincinnati, OH"},{"name":"10University of Cincinnati College of Medicine, Cincinnati, OH"},{"name":"11Global Health Center, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"McElhinney","sequence":"additional","affiliation":[{"name":"9Division of Hematology, Department of Pediatrics, Cincinnati Children\u2019s Hospital, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thad A.","family":"Howard","sequence":"additional","affiliation":[{"name":"9Division of Hematology, Department of Pediatrics, Cincinnati Children\u2019s Hospital, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Aygun","sequence":"additional","affiliation":[{"name":"12Cohen Children\u2019s Medical Center, New Hyde Park, NY"},{"name":"13Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Stuber","sequence":"additional","affiliation":[{"name":"9Division of Hematology, Department of Pediatrics, Cincinnati Children\u2019s Hospital, Cincinnati, OH"},{"name":"11Global Health Center, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lane","sequence":"additional","affiliation":[{"name":"9Division of Hematology, Department of Pediatrics, Cincinnati Children\u2019s Hospital, Cincinnati, OH"},{"name":"10University of Cincinnati College of Medicine, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa S.","family":"Latham","sequence":"additional","affiliation":[{"name":"9Division of Hematology, Department of Pediatrics, Cincinnati Children\u2019s Hospital, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9582-0594","authenticated-orcid":false,"given":"Russell E.","family":"Ware","sequence":"additional","affiliation":[{"name":"9Division of Hematology, Department of Pediatrics, Cincinnati Children\u2019s Hospital, Cincinnati, OH"},{"name":"10University of Cincinnati College of Medicine, Cincinnati, OH"},{"name":"11Global Health Center, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2023103114512171500_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/pbc.25705","article-title":"Hydroxyurea therapy for children with sickle cell anemia in sub-Saharan Africa: rationale and design of the REACH trial","volume":"63","author":"McGann","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2023103114512171500_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ajh.25034","article-title":"Realizing effectiveness across continents with hydroxyurea: enrollment and baseline characteristics of the multicenter REACH study in sub-Saharan Africa","volume":"93","author":"McGann","year":"2018","journal-title":"Am J Hematol"},{"issue":"2","key":"2023103114512171500_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1813598","article-title":"Hydroxyurea for children with sickle cell anemia in sub-Saharan Africa","volume":"380","author":"Tshilolo","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"2023103114512171500_bib4","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/bloodadvances.2018023069","article-title":"Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children","volume":"2","author":"McGann","year":"2018","journal-title":"Blood Adv"},{"issue":"12","key":"2023103114512171500_bib5","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1128\/JCM.42.12.5636-5643.2004","article-title":"Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays","volume":"42","author":"Rougemont","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"issue":"2","key":"2023103114512171500_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/biomet\/68.2.373","article-title":"On the regression analysis of multivariate failure time data","volume":"68","author":"Prentice","year":"1981","journal-title":"Biometrika"},{"issue":"1","key":"2023103114512171500_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ije\/dyu222","article-title":"Modelling recurrent events: a tutorial for analysis in epidemiology","volume":"44","author":"Amorim","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2023103114512171500_bib8","unstructured":"World Health Organization\n          . World malaria report\u00a02021.. Accessed 22 March 2022. https:\/\/www.who.int\/publications\/i\/item\/9789240040496."},{"issue":"11","key":"2023103114512171500_bib9","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMp2116591","article-title":"A malaria vaccine for Africa \u2013 an important step in a century-long quest","volume":"386","author":"Alonso","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"2023103114512171500_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pt.2011.02.004","article-title":"Sickle cell disease and malaria morbidity: a tale with two tails","volume":"27","author":"Williams","year":"2011","journal-title":"Trends Parasitol"},{"issue":"10","key":"2023103114512171500_bib11","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1182\/blood-2010-01-265249","article-title":"High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya","volume":"116","author":"McAuley","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2023103114512171500_bib12","doi-asserted-by":"crossref","first-page":"e26745","DOI":"10.1002\/pbc.26745","article-title":"Lack of mortality in 22 children with sickle cell anemia and severe malaria anemia","volume":"65","author":"Opoka","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"24","key":"2023103114512171500_bib13","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2017-06-788935","article-title":"Novel use of hydroxyurea in an African region with malaria (NOHARM): a trial for children with sickle cell anemia","volume":"130","author":"Opoka","year":"2017","journal-title":"Blood"},{"key":"2023103114512171500_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1475-2875-8-237","article-title":"Presumptive treatment with sulphadozine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anaemia in Uganda: a randomized controlled trial","volume":"8","author":"Nakibuuka","year":"2009","journal-title":"Malar J"},{"issue":"10179","key":"2023103114512171500_bib15","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(18)32224-4","article-title":"Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomized, controlled, superiority trial","volume":"393","author":"Kajubi","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"2023103114512171500_bib16","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood.V92.7.2527","article-title":"Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency","volume":"92","author":"Cappadoro","year":"1998","journal-title":"Blood"},{"issue":"10","key":"2023103114512171500_bib17","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/S2352-3026(15)00152-0","article-title":"Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study","volume":"2","author":"Uyoga","year":"2015","journal-title":"Lancet Haematol"},{"issue":"11","key":"2023103114512171500_bib18","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ng.3107","article-title":"Reappraisal of known malaria resistance loci in a large multicenter study","volume":"46","author":"Malaria Genomic Epidemiology Network","year":"2014","journal-title":"Nat Genet"},{"key":"2023103114512171500_bib19","doi-asserted-by":"crossref","first-page":"e43154","DOI":"10.7554\/eLife.43154","article-title":"Collider bias and the apparent protective effect of glucose-6-phosphate dehydrogenase deficiency on cerebral malaria","volume":"8","author":"Watson","year":"2019","journal-title":"Elife"},{"issue":"1","key":"2023103114512171500_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0950-3536(98)80069-3","article-title":"The population genetics of the haemoglobinopathies","volume":"11","author":"Flint","year":"1998","journal-title":"Baillieres Clin Haematol"},{"issue":"5","key":"2023103114512171500_bib21","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1371\/journal.pmed.0030158","article-title":"The effect of alpha+-thalassaemia on the incidence of malaria and other diseases in children living on the coast of Kenya","volume":"3","author":"Wambua","year":"2006","journal-title":"PLoS Med"},{"issue":"11","key":"2023103114512171500_bib22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ng1660","article-title":"Negative epistasis between the malaria-protective effects of alpha+ thalassemia and the sickle cell trait","volume":"37","author":"Williams","year":"2005","journal-title":"Nat Genet"},{"key":"2023103114512171500_bib23","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.3389\/fimmu.2018.03005","article-title":"Neutrophils and malaria","volume":"9","author":"Aitken","year":"2018","journal-title":"Front Immunol"},{"key":"2023103114512171500_bib24","doi-asserted-by":"crossref","first-page":"e12912","DOI":"10.1111\/pim.12912","article-title":"Neutrophils in malaria: the good, the bad or the ugly?","author":"Pollenus","year":"2022","journal-title":"Parasite Immunol"},{"issue":"26","key":"2023103114512171500_bib25","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","article-title":"How I use hydroxyurea to treat young patients with sickle cell anemia","volume":"115","author":"Ware","year":"2010","journal-title":"Blood"},{"issue":"7015","key":"2023103114512171500_bib26","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/bmj.311.7015.1273","article-title":"The incidence of malaria after splenectomy in Papua New Guinea","volume":"311","author":"Boone","year":"1995","journal-title":"BMJ"},{"issue":"11","key":"2023103114512171500_bib27","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.trstmh.2005.03.008","article-title":"Falciparum malaria after splenectomy: a prospective controlled study of 33 previously splenectomized Malawian adults","volume":"99","author":"Bach","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"2023103114512171500_bib28","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood-2004-12-4973","article-title":"Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study","volume":"106","author":"Hankins","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2023103114512171500_bib29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pbc.21271","article-title":"Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea","volume":"50","author":"Hankins","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2023103114512171500_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/trstmh\/tru040","article-title":"Spleen volume and clinical disease manifestations of severe Plasmodium falciparum malaria in African children","volume":"108","author":"Kotlyar","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"2023103114512171500_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood-2010-04-202911","article-title":"The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology","volume":"117","author":"Buffet","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2023103114512171500_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pt.2020.03.001","article-title":"The human spleen in malaria: filter or shelter?","volume":"36","author":"Henry","year":"2020","journal-title":"Trends Parasitol"},{"issue":"2","key":"2023103114512171500_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/02724936.1988.11748549","article-title":"Persistent gross splenomegaly in Nigerian patients with sickle cell anaemia: relationship to malaria","volume":"8","author":"Adekile","year":"1988","journal-title":"Ann Trop Paediatr"},{"issue":"2","key":"2023103114512171500_bib34","first-page":"121","article-title":"Spleen measurement in malaria","volume":"3","author":"Hackett","year":"1944","journal-title":"Natl Mal Soc J"},{"key":"2023103114512171500_bib35","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/1475-2875-11-396","article-title":"Foetal haemoglobin and the dynamics of paediatric malaria","volume":"11","author":"Billig","year":"2012","journal-title":"Malar J"},{"issue":"5633","key":"2023103114512171500_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/270171a0","article-title":"Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum","volume":"270","author":"Pasvol","year":"1977","journal-title":"Nature"},{"issue":"7","key":"2023103114512171500_bib37","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood.V92.7.2520","article-title":"Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism","volume":"92","author":"Shear","year":"1998","journal-title":"Blood"},{"issue":"14","key":"2023103114512171500_bib38","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/bloodadvances.2019000399","article-title":"Fetal hemoglobin does not inhibit Plasmodium falciparum growth","volume":"3","author":"Archer","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"2023103114512171500_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-291X(68)90266-0","article-title":"Effect of hydroxyurea on ribonucleotide reductase","volume":"33","author":"Elford","year":"1968","journal-title":"Biochem Biophys Res Commun"},{"issue":"3\u20134","key":"2023103114512171500_bib40","first-page":"163","article-title":"The role of deoxynucleoside triphosphate pools in the inhibition of DNA-excision repair and replication in human cells by hydroxyurea","volume":"131","author":"Snyder","year":"1984","journal-title":"Mutat Res"},{"issue":"9","key":"2023103114512171500_bib41","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1128\/AAC.42.9.2456","article-title":"Antimalarial activities of polyhydroxyphenyl and hydroxamic acid derivatives","volume":"42","author":"Holland","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"2023103114512171500_bib42","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-3024.2006.00907.x","article-title":"Effects of hydroxyurea on malaria, parasite growth and adhesion in experimental models","volume":"28","author":"Pino","year":"2006","journal-title":"Parasite Immunol"},{"issue":"5186","key":"2023103114512171500_bib43","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.7973634","article-title":"Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication","volume":"266","author":"Lori","year":"1994","journal-title":"Science"},{"issue":"3","key":"2023103114512171500_bib44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/422331","article-title":"Iron deficiency and malaria among children living on the coast of Kenya","volume":"190","author":"Nyakeriga","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"2023103114512171500_bib45","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1182\/blood.V84.3.910.910","article-title":"Mode of action of iron (III) chelators as antimalarials: II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis","volume":"84","author":"Lytton","year":"1994","journal-title":"Blood"},{"issue":"3","key":"2023103114512171500_bib46","first-page":"253","article-title":"Empowering newborn screening programs in African countries through establishment of an international collaborative effort","volume":"11","author":"Therrell","year":"2020","journal-title":"J\u00a0Community Genet"},{"issue":"24","key":"2023103114512171500_bib47","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1182\/bloodadvances.2022007698","article-title":"The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology","volume":"6","author":"Green","year":"2022","journal-title":"Blood Adv"},{"issue":"10","key":"2023103114512171500_bib48","doi-asserted-by":"crossref","first-page":"e1458","DOI":"10.1016\/S2214-109X(19)30328-6","article-title":"The epidemiology of sickle cell disease in children recruited in infancy in Kilifi, Kenya: a prospective cohort study","volume":"7","author":"Uyoga","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"3","key":"2023103114512171500_bib49","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S2352-3026(22)00004-7","article-title":"Estimating the risk of child mortality attributable to sickle cell anaemia in sub-Saharan Africa: a\u00a0retrospective, multicentre, case-control study","volume":"9","author":"Ranque","year":"2022","journal-title":"Lancet Haematol"},{"issue":"9","key":"2023103114512171500_bib50","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S2352-4642(22)00153-5","article-title":"Sickle cell anaemia and severe Plasmodium falciparum malaria: a secondary analysis of the Transfusion and Treatment of African Clinical Trial (TRACT)","volume":"6","author":"Uyoga","year":"2022","journal-title":"Lancet Child Adolesc Health"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/141\/12\/1402\/2086757\/blood_bld-2022-017051-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/141\/12\/1402\/2086757\/blood_bld-2022-017051-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T14:51:59Z","timestamp":1698763919000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/141\/12\/1402\/487110\/Hydroxyurea-treatment-is-associated-with-lower"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,3,23]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022017051","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]}}}